XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Revenue:        
Total revenue $ 31,958 $ 27,198 $ 62,510 $ 52,131
Operating costs and expenses:        
Cost, Product and Service [Extensible Enumeration] Product Sales [Member] Product Sales [Member] Product Sales [Member] Product Sales [Member]
Product costs $ 7,101 $ 5,738 $ 15,904 $ 11,005
Research and development 10,229 12,924 18,893 25,667
Selling, general and administrative 13,093 12,967 25,630 26,203
Acquired intangible asset amortization 876 867 1,746 1,780
Restructuring expense   1,282   1,282
Contingent consideration expense   3   6
Total operating costs and expenses 31,299 33,781 62,173 65,943
Operating income (loss) 659 (6,583) 337 (13,812)
Other expense, net:        
Interest expense, net (881) (884) (1,777) (1,710)
Foreign exchange loss (72) (75) (117) (200)
Investment income, net 460 177 999 349
Other expense, net (493) (782) (895) (1,561)
Income (loss) before income taxes 166 (7,365) (558) (15,373)
Income tax benefit (expense) 81 (368) 19 (203)
Net income (loss) $ 247 $ (7,733) $ (539) $ (15,576)
Basic net income (loss) per share $ 0.02 $ (0.55) $ (0.04) $ (1.11)
Diluted net income (loss) per share $ 0.02 $ (0.55) $ (0.04) $ (1.11)
Weighted average number of shares outstanding:        
Basic 14,152 14,030 14,127 14,010
Diluted 14,182 14,030 14,127 14,010
Product Sales [Member]        
Revenue:        
Total revenue $ 18,099 $ 15,350 $ 36,926 $ 29,584
Royalties and License Fees [Member]        
Revenue:        
Total revenue 11,411 9,429 20,590 18,194
Research, Development and Other [Member]        
Revenue:        
Total revenue $ 2,448 $ 2,419 $ 4,994 $ 4,353